Arcutis Biotherapeutics Inc (ARQT)

May 16, 2025

When the Price of (ARQT) Talks, People Listen - news.stocktradersdaily.com

May 16, 2025

May 16, 2025

ARQT: Key Insights from Genital Psoriasis Consensus Statements | - GuruFocus

May 16, 2025

May 16, 2025

New Consensus Statements on Impact of Genital Psoriasis on Patie - GuruFocus

May 16, 2025

May 15, 2025

New Consensus Statements on Impact of Genital Psoriasis on Patients from Genital Psoriasis Wellness Consortium Published in Journal of the European Academy of Dermatology and Venereology Clinical Practice - The Manila Times

May 15, 2025

May 15, 2025

Arcutis Biotherapeutics Publishes Expert Consensus on Genital Psoriasis to Enhance Patient Care and Treatment Decision-Making - Nasdaq

May 15, 2025

May 15, 2025

Medical Breakthrough: Experts Release 14 Game-Changing Guidelines for Genital Psoriasis Treatment - Stock Titan

May 15, 2025

May 14, 2025

Chronic Hand Eczema Pipeline 2025: FDA Updates, Therapy - openPR.com

May 14, 2025

May 14, 2025

Chronic Hand Eczema Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Incyte Corp, LEO Pharma, Asana BioSciences, Arcutis Biotherapeutics - Barchart.com

May 14, 2025

May 14, 2025

Director’s Bold Move: A Major Investment in Arcutis Biotherapeutics - TipRanks

May 14, 2025

May 10, 2025

Analysts Offer Insights on Healthcare Companies: Arcutis Biotherapeutics (ARQT) and AMN Healthcare Services (AMN) - The Globe and Mail

May 10, 2025

May 09, 2025

Arcutis outlines growth potential with ZORYVE expansions and market penetration - MSN

May 09, 2025

May 09, 2025

Earnings Update: Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts - simplywall.st

May 09, 2025

May 09, 2025

Arcutis Biotherapeutics, Inc. (ARQT) Reports Q1 Loss, Tops Revenue Estimates - MSN

May 09, 2025

May 08, 2025

Arcutis Biotherapeutics: Zoryve foam treatment resulted in major improvements - Yahoo Finance

May 08, 2025

May 08, 2025

Arcutis Biotherapeutics First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

May 08, 2025

May 08, 2025

Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Q1 2025 Earnings Call Transcript - Insider Monkey

May 08, 2025

May 07, 2025

Arcutis Biotherapeutics Reports Strong Q1 Earnings Growth - TipRanks

May 07, 2025

May 07, 2025

Jefferies lifts Arcutis stock target to $20 on strong sales By Investing.com - Investing.com South Africa

May 07, 2025

May 07, 2025

ZORYVE foam shows promise in psoriasis treatment By Investing.com - Investing.com South Africa

May 07, 2025

May 07, 2025

ZORYVE foam shows promise in psoriasis treatment - Investing.com

May 07, 2025

May 07, 2025

Arcutis Announces Publication of Positive Data from ARRECTOR Tri - GuruFocus

May 07, 2025

May 07, 2025

Arcutis Biotherapeutics (ARQT) Reports Positive Phase 3 Trial Results for Psoriasis Treatment | ARQT Stock News - GuruFocus

May 07, 2025

May 07, 2025

Arcutis Announces Publication of Positive Data from ARRECTOR Trial Evaluating ZORYVE® (roflumilast) Foam 0.3% in Individuals with Psoriasis in Journal of American Medical Association Dermatology - The Manila Times

May 07, 2025

May 07, 2025

Arcutis Announces Publication of Positive Data from Arrector Trial Evaluating Zoryve®? (Roflumilast) Foam 0.3% in Individuals with Psoriasis in Journal of American Medical Association Dermatology - marketscreener.com

May 07, 2025

May 07, 2025

Jefferies lifts Arcutis stock target to $20 on strong sales - Investing.com Australia

May 07, 2025

May 07, 2025

Arcutis Biotherapeutics Inc (ARQT) Q1 2025 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance

May 07, 2025

May 07, 2025

Decoding Arcutis Biotherapeutics Inc (ARQT): A Strategic SWOT In - GuruFocus

May 07, 2025

May 07, 2025

Arcutis Biotherapeutics Reports Strong Q1 2025 Growth - TipRanks

May 07, 2025

May 07, 2025

Arcutis (ARQT) Reports Strong Q1 Growth on Rising ZORYVE Demand - GuruFocus

May 07, 2025

May 06, 2025

Earnings call transcript: Arcutis Biotherapeutics Q1 2025 earnings beat estimates - Investing.com

May 06, 2025

May 06, 2025

Earnings call transcript: Arcutis Biotherapeutics Q1 2025 earnings beat estimates By Investing.com - Investing.com India

May 06, 2025

May 06, 2025

Arcutis Biotherapeutics stock falls despite Q1 revenue beat By Investing.com - Investing.com Nigeria

May 06, 2025

May 06, 2025

Arcutis Biotherapeutics stock falls despite Q1 revenue beat - Investing.com

May 06, 2025

May 06, 2025

Arcutis Biotherapeutics (ARQT) Q1 Performance Surpasses Expectations - GuruFocus

May 06, 2025

May 06, 2025

Arcutis Biotherapeutics Inc (ARQT) Q1 2025 Earnings: EPS Loss of $0.20 Beats Estimate, Revenue Surpasses Forecast at $63.8 Million - GuruFocus

May 06, 2025

May 06, 2025

Arcutis Q1 2025 slides: Revenue soars 196% YoY despite seasonal headwinds - Investing.com India

May 06, 2025

May 06, 2025

ARCUTIS BIOTHERAPEUTICS Earnings Results: $ARQT Reports Quarterly Earnings - Nasdaq

May 06, 2025

May 06, 2025

Arcutis Announces First Quarter 2025 Financial Results and Provides Business Update - The Manila Times

May 06, 2025

May 06, 2025

Arcutis Biotherapeutics (ARQT) Surpasses Q1 Revenue Expectations with Robust Growth | ARQT Stock News - GuruFocus

May 06, 2025

May 06, 2025

Earnings Flash (ARQT) Arcutis Biotherapeutics Reports Q1 Revenue $65.8M, vs. FactSet Est of $62.2M - marketscreener.com

May 06, 2025

May 06, 2025

Arcutis Q1 Earnings: ZORYVE Sales Surge 196% to $64M as Coverage Expands | ARQT Stock News - Stock Titan

May 06, 2025

May 06, 2025

Arcutis Biotherapeutics (ARQT) Q1 Earnings Preview - GuruFocus

May 06, 2025

May 06, 2025

How to Take Advantage of moves in (ARQT) - news.stocktradersdaily.com

May 06, 2025

May 05, 2025

What To Expect From Arcutis Biotherapeutics Inc (ARQT) Q1 2025 E - GuruFocus

May 05, 2025

May 05, 2025

Chronic Hand Eczema Pipeline 2025: FDA Approvals, Therapies, - openPR.com

May 05, 2025

May 05, 2025

What To Expect From Arcutis Biotherapeutics Inc (ARQT) Q1 2025 Earnings - GuruFocus

May 05, 2025